Fast-Acting Cold Sore Treatment Options
Recognising Early Warning Signs
The key to effective cold sore treatment lies in early recognition of symptoms. Most people experience a tingling, burning, or itching sensation around the lip area 12-24 hours before visible blisters appear. This prodrome stage is the optimal time to begin antiviral treatment for maximum effectiveness.
Prescription Antiviral Medications
Aciclovir tablets are the most commonly prescribed treatment for cold sores in the UK. Taking aciclovir 400mg five times daily at the first sign of symptoms can reduce healing time by 1-2 days and may lessen the severity of symptoms. EverydayMeds offers aciclovir tablets and cream options that can be prescribed following an online consultation. Valaciclovir is an alternative antiviral that requires less frequent dosing, typically taken twice daily for 5 days.
Topical Treatment Applications
Aciclovir 5% cream can be applied directly to the affected area every four hours during waking hours. While topical treatments are less effective than oral medications, they may provide some symptom relief when applied early. The cream should be applied with clean hands or a cotton swab to prevent spreading the infection.
Immediate Relief Strategies
Cold compresses applied for 10-15 minutes several times daily can help reduce pain and swelling. Avoid hot or warm compresses as heat may worsen symptoms. Over-the-counter pain relievers like paracetamol or ibuprofen can help manage discomfort. Keeping the area moisturised with petroleum jelly may prevent cracking and secondary bacterial infection.
Prevention and Lifestyle Measures
Identifying personal triggers can help prevent future outbreaks. Common triggers include stress, fatigue, sun exposure, hormonal changes, and illness. Using lip balm with SPF 30 or higher daily can protect against UV-triggered episodes. Maintaining good hygiene, avoiding close contact during active outbreaks, and not sharing personal items like lip balm or utensils helps prevent transmission to others.
